CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 29,453 enrolled
Drug / intervention
Synthetic Mammography + Digital Breast Tomosynthesis +1 moreradiation
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02835625
NCT02835625N/ACompleted
CompareCT.gov

Digital Breast Tomosynthesis - The Future Screening Tool for Breast Cancer?

Norwegian Institute of Public Health·interventional·Posted Jul 18, 2016·Updated Aug 28, 2024

In Brief

A clinical study evaluating Synthetic Mammography + Digital Breast Tomosynthesis and Digital mammography for Breast Neoplasms. Completed, enrolled 29,453 participants across 2 sites.

Detailed Summary

Compare synthetic mammography+digital breast tomosynthesis (SM+DBT) with digital mammography (DM) as a screening tool for women aged 50-69 years, invited to participate in the Norwegian Breast Cancer Screening Program at the screening unit in Bergen, Norway, with regard to early performance measures, including prognostic and predictive tumor characteristics, radiation doses and cost-effectiveness.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBreast Neoplasms
CountriesNorway
CollaboratorsHaukeland University Hospital, University of Oslo, The Research Council of Norway

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedJul 18, 2016
Enrollment StartJan 1, 2016
Primary CompletionJun 1, 2018
Study CompletionMay 1, 2021
TodayJul 2, 2026
Enrollment to primary: 2.4 yearsPosted 10.0 years ago

Interventions

Synthetic Mammography + Digital Breast Tomosynthesisradiation

Two-view tomosynthesis performed with GE Senoclaire 3D Breast Tomosynthesis.

Digital mammographyradiation

Two-view digital mammography performed with GE Senoclaire 3D Breast Tomosynthesis.